カテゴリ： 世界, 医療/バイオ, QYResearch

抗凝固薬の世界市場2023年：注射用抗凝固薬、経口抗凝固薬

■ 英語タイトル：Global Anticoagulant Medicines Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8670）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8670
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[抗凝固薬の世界市場2023年：注射用抗凝固薬、経口抗凝固薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は抗凝固薬のグローバル市場について調査・分析し、世界の抗凝固薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（注射用抗凝固薬、経口抗凝固薬）、用途別セグメント分析（病院薬局、小売店、オンライン薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott Laboratories、Aspen、AstraZeneca、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Genentech (Roche)、Johnson & Johnson.、Lilly、Merck、Otsuka、Pfizer、Sanofi、The Medicines Companyなどが含まれています。抗凝固薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、抗凝固薬市場規模を算出する際に考慮しました。

・抗凝固薬市場の概要
- 抗凝固薬の種類別セグメント
- 世界の抗凝固薬市場規模：タイプ別分析（注射用抗凝固薬、経口抗凝固薬）
- 抗凝固薬の用途別セグメント
- 世界の抗凝固薬市場規模：用途別分析（病院薬局、小売店、オンライン薬局、その他）
- 世界の抗凝固薬市場規模予測（2018年-2029年）

・抗凝固薬市場の成長トレンド
- 抗凝固薬の地域別市場規模（2018年-2029年）
- 抗凝固薬市場ダイナミクス
- 抗凝固薬の業界動向
- 抗凝固薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：注射用抗凝固薬、経口抗凝固薬
- 世界の抗凝固薬のタイプ別市場規模（2018年-2023年）
- 世界の抗凝固薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院薬局、小売店、オンライン薬局、その他
- 世界の抗凝固薬の用途別市場規模（2018年-2023年）
- 世界の抗凝固薬の用途別市場規模（2024年-2029年）

・抗凝固薬の地域別市場規模
- 北米の抗凝固薬市場規模（2018年-2029年）
- 米国の抗凝固薬市場規模（2018年-2029年）
- ヨーロッパの抗凝固薬市場規模（2018年-2029年）
- アジア太平洋の抗凝固薬市場規模（2018年-2029年）
- 中国の抗凝固薬市場規模（2018年-2029年）
- 日本の抗凝固薬市場規模（2018年-2029年）
- 韓国の抗凝固薬市場規模（2018年-2029年）
- インドの抗凝固薬市場規模（2018年-2029年）
- オーストラリアの抗凝固薬市場規模（2018年-2029年）
- 中南米の抗凝固薬市場規模（2018年-2029年）
- 中東・アフリカの抗凝固薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Abbott Laboratories、Aspen、AstraZeneca、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Genentech (Roche)、Johnson & Johnson.、Lilly、Merck、Otsuka、Pfizer、Sanofi、The Medicines Company

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Anticoagulant Medicines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Anticoagulant Medicines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anticoagulant Medicines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Anticoagulant Medicines in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Anticoagulant Medicines include Abbott Laboratories, Aspen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Genentech (Roche) and Johnson & Johnson., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anticoagulant Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulant Medicines.
The Anticoagulant Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anticoagulant Medicines market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticoagulant Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Aspen
AstraZeneca
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Genentech (Roche)
Johnson & Johnson.
Lilly
Merck
Otsuka
Pfizer
Sanofi
The Medicines Company
Segment by Type
Injectable Anticoagulant Medicines
Oral Anticoagulant Medicines
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anticoagulant Medicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulant Medicines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Injectable Anticoagulant Medicines
1.2.3 Oral Anticoagulant Medicines
1.3 Market by Application
1.3.1 Global Anticoagulant Medicines Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulant Medicines Market Perspective (2018-2029)
2.2 Anticoagulant Medicines Growth Trends by Region
2.2.1 Global Anticoagulant Medicines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anticoagulant Medicines Historic Market Size by Region (2018-2023)
2.2.3 Anticoagulant Medicines Forecasted Market Size by Region (2024-2029)
2.3 Anticoagulant Medicines Market Dynamics
2.3.1 Anticoagulant Medicines Industry Trends
2.3.2 Anticoagulant Medicines Market Drivers
2.3.3 Anticoagulant Medicines Market Challenges
2.3.4 Anticoagulant Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulant Medicines Players by Revenue
3.1.1 Global Top Anticoagulant Medicines Players by Revenue (2018-2023)
3.1.2 Global Anticoagulant Medicines Revenue Market Share by Players (2018-2023)
3.2 Global Anticoagulant Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticoagulant Medicines Revenue
3.4 Global Anticoagulant Medicines Market Concentration Ratio
3.4.1 Global Anticoagulant Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Medicines Revenue in 2022
3.5 Anticoagulant Medicines Key Players Head office and Area Served
3.6 Key Players Anticoagulant Medicines Product Solution and Service
3.7 Date of Enter into Anticoagulant Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anticoagulant Medicines Breakdown Data by Type
4.1 Global Anticoagulant Medicines Historic Market Size by Type (2018-2023)
4.2 Global Anticoagulant Medicines Forecasted Market Size by Type (2024-2029)
5 Anticoagulant Medicines Breakdown Data by Application
5.1 Global Anticoagulant Medicines Historic Market Size by Application (2018-2023)
5.2 Global Anticoagulant Medicines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anticoagulant Medicines Market Size (2018-2029)
6.2 North America Anticoagulant Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anticoagulant Medicines Market Size by Country (2018-2023)
6.4 North America Anticoagulant Medicines Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anticoagulant Medicines Market Size (2018-2029)
7.2 Europe Anticoagulant Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anticoagulant Medicines Market Size by Country (2018-2023)
7.4 Europe Anticoagulant Medicines Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulant Medicines Market Size (2018-2029)
8.2 Asia-Pacific Anticoagulant Medicines Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anticoagulant Medicines Market Size by Region (2018-2023)
8.4 Asia-Pacific Anticoagulant Medicines Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anticoagulant Medicines Market Size (2018-2029)
9.2 Latin America Anticoagulant Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anticoagulant Medicines Market Size by Country (2018-2023)
9.4 Latin America Anticoagulant Medicines Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulant Medicines Market Size (2018-2029)
10.2 Middle East & Africa Anticoagulant Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anticoagulant Medicines Market Size by Country (2018-2023)
10.4 Middle East & Africa Anticoagulant Medicines Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anticoagulant Medicines Introduction
11.1.4 Abbott Laboratories Revenue in Anticoagulant Medicines Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Aspen
11.2.1 Aspen Company Detail
11.2.2 Aspen Business Overview
11.2.3 Aspen Anticoagulant Medicines Introduction
11.2.4 Aspen Revenue in Anticoagulant Medicines Business (2018-2023)
11.2.5 Aspen Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Anticoagulant Medicines Introduction
11.3.4 AstraZeneca Revenue in Anticoagulant Medicines Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Anticoagulant Medicines Introduction
11.4.4 Bayer Revenue in Anticoagulant Medicines Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Anticoagulant Medicines Introduction
11.5.4 Boehringer Ingelheim Revenue in Anticoagulant Medicines Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Anticoagulant Medicines Introduction
11.6.4 Bristol-Myers Squibb Revenue in Anticoagulant Medicines Business (2018-2023)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Detail
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Anticoagulant Medicines Introduction
11.7.4 Daiichi Sankyo Revenue in Anticoagulant Medicines Business (2018-2023)
11.7.5 Daiichi Sankyo Recent Development
11.8 Genentech (Roche)
11.8.1 Genentech (Roche) Company Detail
11.8.2 Genentech (Roche) Business Overview
11.8.3 Genentech (Roche) Anticoagulant Medicines Introduction
11.8.4 Genentech (Roche) Revenue in Anticoagulant Medicines Business (2018-2023)
11.8.5 Genentech (Roche) Recent Development
11.9 Johnson & Johnson.
11.9.1 Johnson & Johnson. Company Detail
11.9.2 Johnson & Johnson. Business Overview
11.9.3 Johnson & Johnson. Anticoagulant Medicines Introduction
11.9.4 Johnson & Johnson. Revenue in Anticoagulant Medicines Business (2018-2023)
11.9.5 Johnson & Johnson. Recent Development
11.10 Lilly
11.10.1 Lilly Company Detail
11.10.2 Lilly Business Overview
11.10.3 Lilly Anticoagulant Medicines Introduction
11.10.4 Lilly Revenue in Anticoagulant Medicines Business (2018-2023)
11.10.5 Lilly Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Anticoagulant Medicines Introduction
11.11.4 Merck Revenue in Anticoagulant Medicines Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Otsuka
11.12.1 Otsuka Company Detail
11.12.2 Otsuka Business Overview
11.12.3 Otsuka Anticoagulant Medicines Introduction
11.12.4 Otsuka Revenue in Anticoagulant Medicines Business (2018-2023)
11.12.5 Otsuka Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Detail
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Anticoagulant Medicines Introduction
11.13.4 Pfizer Revenue in Anticoagulant Medicines Business (2018-2023)
11.13.5 Pfizer Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Anticoagulant Medicines Introduction
11.14.4 Sanofi Revenue in Anticoagulant Medicines Business (2018-2023)
11.14.5 Sanofi Recent Development
11.15 The Medicines Company
11.15.1 The Medicines Company Company Detail
11.15.2 The Medicines Company Business Overview
11.15.3 The Medicines Company Anticoagulant Medicines Introduction
11.15.4 The Medicines Company Revenue in Anticoagulant Medicines Business (2018-2023)
11.15.5 The Medicines Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anticoagulant Medicines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Injectable Anticoagulant Medicines
Table 3. Key Players of Oral Anticoagulant Medicines
Table 4. Global Anticoagulant Medicines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Anticoagulant Medicines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Anticoagulant Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Anticoagulant Medicines Market Share by Region (2018-2023)
Table 8. Global Anticoagulant Medicines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Anticoagulant Medicines Market Share by Region (2024-2029)
Table 10. Anticoagulant Medicines Market Trends
Table 11. Anticoagulant Medicines Market Drivers
Table 12. Anticoagulant Medicines Market Challenges
Table 13. Anticoagulant Medicines Market Restraints
Table 14. Global Anticoagulant Medicines Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Anticoagulant Medicines Market Share by Players (2018-2023)
Table 16. Global Top Anticoagulant Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Medicines as of 2022)
Table 17. Ranking of Global Top Anticoagulant Medicines Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Anticoagulant Medicines Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anticoagulant Medicines Product Solution and Service
Table 21. Date of Enter into Anticoagulant Medicines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anticoagulant Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Anticoagulant Medicines Revenue Market Share by Type (2018-2023)
Table 25. Global Anticoagulant Medicines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Anticoagulant Medicines Revenue Market Share by Type (2024-2029)
Table 27. Global Anticoagulant Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Anticoagulant Medicines Revenue Market Share by Application (2018-2023)
Table 29. Global Anticoagulant Medicines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Anticoagulant Medicines Revenue Market Share by Application (2024-2029)
Table 31. North America Anticoagulant Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Anticoagulant Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Anticoagulant Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Anticoagulant Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Anticoagulant Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Anticoagulant Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Anticoagulant Medicines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Anticoagulant Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Anticoagulant Medicines Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Anticoagulant Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Anticoagulant Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Anticoagulant Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Anticoagulant Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Anticoagulant Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Anticoagulant Medicines Market Size by Country (2024-2029) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Anticoagulant Medicines Product
Table 49. Abbott Laboratories Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Aspen Company Detail
Table 52. Aspen Business Overview
Table 53. Aspen Anticoagulant Medicines Product
Table 54. Aspen Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 55. Aspen Recent Development
Table 56. AstraZeneca Company Detail
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca Anticoagulant Medicines Product
Table 59. AstraZeneca Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Bayer Company Detail
Table 62. Bayer Business Overview
Table 63. Bayer Anticoagulant Medicines Product
Table 64. Bayer Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Boehringer Ingelheim Company Detail
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Anticoagulant Medicines Product
Table 69. Boehringer Ingelheim Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Bristol-Myers Squibb Company Detail
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Anticoagulant Medicines Product
Table 74. Bristol-Myers Squibb Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. Daiichi Sankyo Company Detail
Table 77. Daiichi Sankyo Business Overview
Table 78. Daiichi Sankyo Anticoagulant Medicines Product
Table 79. Daiichi Sankyo Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 80. Daiichi Sankyo Recent Development
Table 81. Genentech (Roche) Company Detail
Table 82. Genentech (Roche) Business Overview
Table 83. Genentech (Roche) Anticoagulant Medicines Product
Table 84. Genentech (Roche) Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 85. Genentech (Roche) Recent Development
Table 86. Johnson & Johnson. Company Detail
Table 87. Johnson & Johnson. Business Overview
Table 88. Johnson & Johnson. Anticoagulant Medicines Product
Table 89. Johnson & Johnson. Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 90. Johnson & Johnson. Recent Development
Table 91. Lilly Company Detail
Table 92. Lilly Business Overview
Table 93. Lilly Anticoagulant Medicines Product
Table 94. Lilly Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 95. Lilly Recent Development
Table 96. Merck Company Detail
Table 97. Merck Business Overview
Table 98. Merck Anticoagulant Medicines Product
Table 99. Merck Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Otsuka Company Detail
Table 102. Otsuka Business Overview
Table 103. Otsuka Anticoagulant Medicines Product
Table 104. Otsuka Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 105. Otsuka Recent Development
Table 106. Pfizer Company Detail
Table 107. Pfizer Business Overview
Table 108. Pfizer Anticoagulant Medicines Product
Table 109. Pfizer Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 110. Pfizer Recent Development
Table 111. Sanofi Company Detail
Table 112. Sanofi Business Overview
Table 113. Sanofi Anticoagulant Medicines Product
Table 114. Sanofi Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 115. Sanofi Recent Development
Table 116. The Medicines Company Company Detail
Table 117. The Medicines Company Business Overview
Table 118. The Medicines Company Anticoagulant Medicines Product
Table 119. The Medicines Company Revenue in Anticoagulant Medicines Business (2018-2023) & (US$ Million)
Table 120. The Medicines Company Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticoagulant Medicines Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Anticoagulant Medicines Market Share by Type: 2022 VS 2029
Figure 3. Injectable Anticoagulant Medicines Features
Figure 4. Oral Anticoagulant Medicines Features
Figure 5. Global Anticoagulant Medicines Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Anticoagulant Medicines Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Anticoagulant Medicines Report Years Considered
Figure 12. Global Anticoagulant Medicines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Anticoagulant Medicines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Anticoagulant Medicines Market Share by Region: 2022 VS 2029
Figure 15. Global Anticoagulant Medicines Market Share by Players in 2022
Figure 16. Global Top Anticoagulant Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Medicines as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Anticoagulant Medicines Revenue in 2022
Figure 18. North America Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Anticoagulant Medicines Market Share by Country (2018-2029)
Figure 20. United States Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Anticoagulant Medicines Market Share by Country (2018-2029)
Figure 24. Germany Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Anticoagulant Medicines Market Share by Region (2018-2029)
Figure 32. China Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Anticoagulant Medicines Market Share by Country (2018-2029)
Figure 40. Mexico Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Anticoagulant Medicines Market Share by Country (2018-2029)
Figure 44. Turkey Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Anticoagulant Medicines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 47. Aspen Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 52. Daiichi Sankyo Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 53. Genentech (Roche) Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 54. Johnson & Johnson. Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 55. Lilly Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 56. Merck Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 57. Otsuka Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 59. Sanofi Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 60. The Medicines Company Revenue Growth Rate in Anticoagulant Medicines Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 希少疾病用医薬品の世界市場2023年：腫瘍内科、呼吸器内科、神経内科、血液内科、内分泌内科、循環器内科、代謝疾患、その他
  • 一般用医薬品の世界市場2023年：消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他
  • ポイントオブケア（POC）/迅速診断の世界市場2023年：迅速検査、分子診断
  • 四肢麻痺治療の世界市場2023年：経口、点滴、その他
  • 医療機器の世界市場2023年：体外診断、循環器、画像診断、整形外科、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8670 )"抗凝固薬の世界市場2023年：注射用抗凝固薬、経口抗凝固薬" (英文：Global Anticoagulant Medicines Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。